Login / Signup

Weekly iron-folic acid supplements containing 2.8 mg folic acid are associated with a lower risk of neural tube defects than the current practice of 0.4 mg: a randomised controlled trial in Malaysia.

Kaitlyn L I SamsonSu Peng LohSiew Siew LeeDian C SulistyoningrumGeok Lin KhorZalilah Binti Mohd ShariffIrmi Zarina IsmaiLisa N YellandShalem LeemaqzMaria MakridesJennifer A HutcheonMarion L RocheCrystal D KarakochukTimothy J Green
Published in: BMJ global health (2021)
This trial is registered with the Australian New Zealand Clinical Trial Registry (ACTRN12619000818134).
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • study protocol
  • primary care
  • healthcare
  • open label
  • double blind
  • randomized controlled trial
  • quality improvement
  • iron deficiency